Non-psychoactive cannabinoid may enable drug addiction recovery

An animal study finds that cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may help reduce the risk of drug and alcohol relapse. The research, conducted by the Scripps Research Institute, was funded by the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, both part of the National Institutes of Health.

The researchers applied a gel containing CBD every day for a week to the skin of the rats with a history of daily alcohol or cocaine self-administration. The CBD appeared to be effective in reducing reinstatement of drug-taking — considered a model of drug and alcohol relapse.  It also reduced anxiety and impulsivity often associated with drug dependence. Notably, the reduced reinstatement, which was induced by stress or drug-related environmental cues, lasted for five months after the initial treatment was discontinued, when CBD was no longer detectable in either blood or brain.

Full story at drugabuse.org

10 Percent of Americans Have Had Drug Use Disorder But Many Go Untreated: Study

An estimated 10 percent of Americans have had a drug use disorder at some time in their lives, but many have gone untreated, according to a new study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Only about one-quarter of people who have ever had a drug use disorder received treatment, the study found.

“Based on these findings, more than 23 million adults in the United States have struggled with problematic drug use,” George F. Koob, PhD, NIAAA Director, said in a news release. “Given these numbers, and other recent findings about the prevalence and under-treatment of alcohol use disorder in the U.S., it is vitally important that we continue our efforts to understand the underlying causes of drug and alcohol addiction, their relationship to other psychiatric conditions and the most effective forms of treatment.”

Full story of Americans with drug use disorder at drugfree.org